Page last updated: 2024-08-18

glyoxal and dacarbazine

glyoxal has been researched along with dacarbazine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bischof, H; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Fischer, R; Georgii, A; Glunz, A; Greil, R; Hansmann, ML; Hasenclever, D; Hermann, R; Koch, B; Koch, P; Loeffler, M; Mueller, RP; Munker, R; Oertel, J; Paulus, U; Pfistner, B; Roller, S; Rueffer, U; Schalk, KP; Schober, T; Sieber, M; Stein, H; Tesch, H; von Kalle, K; Willich, N; Worst, P	1
Brosteanu, O; Diehl, V; Hasenclever, D; Loeffler, M	1
Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M	1

Trials

1 trial(s) available for glyoxal and dacarbazine

Article	Year
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Prognosis; Sex Factors; Treatment Outcome; Vinblastine; Vincristine	2004

Article

Year

Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.

Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:2

Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Prognosis; Sex Factors; Treatment Outcome; Vinblastine; Vincristine

2004

Other Studies

2 other study(ies) available for glyoxal and dacarbazine

Article	Year
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease. Annals of hematology, 2004, Volume: 83, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Glyoxal; Hematologic Diseases; Hodgkin Disease; Humans; Ifosfamide; Male; Prednimustine; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vinblastine; Vincristine	2004
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine	2011

Article

Year

Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.

Annals of hematology, 2004, Volume: 83, Issue:3

Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Glyoxal; Hematologic Diseases; Hodgkin Disease; Humans; Ifosfamide; Male; Prednimustine; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vinblastine; Vincristine

2004

Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.

Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3

Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine

2011